Receiving a diagnosis of low ovarian response can raise many questions, uncertainty, and, in many cases, fear. For many women, this diagnosis appears after one or more unsuccessful attempts to achieve pregnancy, or even when beginning fertility testing without having tried before. The feeling is often the same: that time is working against them and that options are narrowing. However, low ovarian response does not mean that the dream of having a baby is over. Today, reproductive medicine offers alternatives designed specifically for these types of cases. One of them is Ovagen, a procedure developed by Ingenes as part of its approach to personalized solutions for complex scenarios. In this article, we explain what low ovarian response is, how it affects fertility, and how Ovagen represents an alternative for women who need more than traditional protocols. What is low ovarian response? Low ovarian response refers to the limited ability of the ovaries to produce eggs in response to hormonal stimulation. In other words, when ovarian stimulation is performed, the number of eggs obtained is lower than expected. This diagnosis can occur in different situations: Low ovarian response is not always related solely to age. In some cases, it appears in younger women with apparently normal studies, which can be even more confusing. How does low ovarian response affect the chances of pregnancy? When few eggs are available, the chances of obtaining viable embryos may decrease. This not only impacts the possibility of achieving pregnancy, but also the emotional experience of the process, as many patients go through cycles with limited results. In these cases, conventional treatments may not be sufficient, and it becomes necessary to consider different strategies, designed specifically to optimize ovarian response and make the most of each patient’s reproductive potential. This is where an approach like Ovagen becomes relevant. What is Ovagen? Ovagen is a procedure developed by Ingenes as an alternative for women with low ovarian response. It is part of the services focused on ovarian regeneration and is designed for patients who require a strategy different from traditional stimulation protocols. Ovagen is not a generic treatment or a universal solution. It is a carefully indicated procedure that is part of a comprehensive and personalized medical plan, always following a complete evaluation of the case. Its goal is to improve the ovarian environment and promote a better response in subsequent assisted reproduction cycles. In which cases can Ovagen be considered? Ovagen may be considered in patients who present: Each case is evaluated individually. Ovagen does not replace a complete medical assessment nor is it indicated automatically. Its use responds to specific clinical criteria defined by the Ingenes medical team. Ovagen as part of a comprehensive approach One of the key aspects of Ovagen is that it is not presented as an isolated procedure, but as part of a comprehensive care model. At Ingenes, low ovarian response is not addressed from a single variable. The evaluation includes: Based on this information, a personalized strategy is designed, which may include Ovagen as part of the plan. This approach avoids standardized solutions and allows each step to be adapted to the patient’s reality. Why don’t all patients with low ovarian response receive the same management? Because not all low responses are the same. Two women with the same diagnosis can have completely different contexts. Some key differences may include: Ovagen is considered when the medical team identifies that it can add value within that specific context. The role of medical evaluation in Ovagen Before considering Ovagen, a thorough medical evaluation is essential. This evaluation not only confirms the diagnosis of low ovarian response, but also helps determine what type of strategy is most appropriate. At Ingenes, this evaluation is carried out from the very first consultation, with the goal of providing clear information and real options, without creating false expectations. The approach is honest and science-based: identifying what can be done and how to do it in the best possible way for each patient. Beyond the number of eggs One of the most common mistakes when discussing low ovarian response is focusing only on the number of eggs. While quantity is important, it is not the only relevant factor. The medical strategy also seeks to optimize: Ovagen is integrated into this approach, with the aim of expanding possibilities within a complex context. Emotional support in cases of low ovarian response Low ovarian response is not only a medical diagnosis; it is also an emotionally demanding experience. Many women arrive at consultation after failed attempts, with accumulated frustration and fear of continuing to try. That is why, at Ingenes, support is not limited to the clinical aspect. The process includes a human, empathetic, and close approach, understanding that each decision carries a deep emotional impact. Ovagen, as part of a comprehensive plan, is explained clearly, without pressure and with full transparency, so that each patient can make informed decisions. What can a patient expect when learning about Ovagen? Learning about Ovagen does not mean committing immediately to a procedure. The first step is always to understand the diagnosis, learn about the available options, and evaluate whether Ovagen is part of an appropriate strategy for the case. During this process, patients can expect: This approach allows decisions to be made from knowledge, not from urgency or fear. Ovagen within the Ingenes care model Ovagen reflects one of Ingenes’ fundamental principles: not all paths to having a baby are the same. For more than 20 years, Ingenes has supported thousands of women with complex diagnoses, understanding that each story requires a different approach. Ovagen arises precisely from that accumulated clinical experience, as an alternative designed for those who need more than conventional options. When low ovarian response requires new strategies Low ovarian response may seem like a difficult obstacle to face, but today there are alternatives designed specifically for this type of scenario. Ovagen is one of them: an option that integrates into a personalized medical plan, based on science, comprehensive